Taken together, our data demonstrate that infusion of cancer patient’s PBMC samples into NSG mice implanted with matched PDX reproducibly engrafts human CD4+ and CD8+ T cells that can persist up to 8 weeks however, the engrafted human T cells demonstrated significant intra- and inter-model variability. This evidence concerns the gene CD8A and cancer.